David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
PUT
Transocean
RIG
$6.25B
| $1.95M | ﹤0.01% |
550,000
+450,000
| +450% | +$1.56M |
|
|
TCRR
2477
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $1.95M | ﹤0.01% |
+88,390
| New | +$2.41M |
|
|
YAC
2478
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
| $1.95M | ﹤0.01% |
+197,658
| New | +$2.04M |
|
2479
CALL
Repligen
RGEN
$10.2B
| $1.94M | ﹤0.01% |
+10,000
| New | +$2.05M |
|
2480
CALL
Targa Resources
TRGP
$63B
| $1.94M | ﹤0.01% |
+61,200
| New | +$1.89M |
|
2481
Dorman Products
DORM
$3.84B
| $1.94M | ﹤0.01% |
18,925
+3,265
| +21% | +$326K |
|
2482
PUT
Fulgent Genetics
FLGT
$545M
| $1.94M | ﹤0.01% |
+20,100
| New | +$2.07M |
|
2483
Pentair
PNR
$10B
| $1.94M | ﹤0.01% |
31,131
-146,518
| -82% | -$8.41M |
|
2484
Under Armour Class C
UA
$2.16B
| $1.94M | ﹤0.01% |
104,897
+12,207
| +13% | +$215K |
|
2485
Dentsply Sirona
XRAY
$2.18B
| $1.94M | ﹤0.01% |
30,336
-64,067
| -68% | -$3.72M |
|
2486
PUT
AngloGold Ashanti
AU
$59.7B
| $1.93M | ﹤0.01% |
88,000
-333,500
| -79% | -$7.48M |
|
2487
CALL
Travel + Leisure Co
TNL
$4.51B
| $1.93M | ﹤0.01% |
31,600
| – | – |
|
|
2488
CALL
Fulgent Genetics
FLGT
$545M
| $1.93M | ﹤0.01% |
+20,000
| New | +$2.06M |
|
|
OSG
2489
DELISTED
Overseas Shipholding Group Inc.
OSG
| $1.93M | ﹤0.01% |
937,465
+176,342
| +23% | +$389K |
|
2490
NexGen Energy
NXE
$7.42B
| $1.93M | ﹤0.01% |
+535,200
| New | +$1.82M |
|
|
TWNT.U
2491
DELISTED
Tailwind Two Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of
TWNT.U
| $1.93M | ﹤0.01% |
+195,342
| New | +$1.95M |
|
|
BBT
2492
Beacon Financial Corp
BBT
$2.66B
| $1.93M | ﹤0.01% |
86,247
-101,356
| -54% | -$2.07M |
|
2493
PUT
ICICI Bank
IBN
$108B
| $1.92M | ﹤0.01% |
120,000
-100,000
| -45% | -$1.63M |
|
2494
CALL
RenaissanceRe
RNR
$13.8B
| $1.92M | ﹤0.01% |
+12,000
| New | +$1.94M |
|
|
OSG
2495
Octave Specialty Group
OSG
$207M
| $1.92M | ﹤0.01% |
114,710
+59,651
| +108% | +$975K |
|
|
CBB
2496
DELISTED
Cincinnati Bell Inc.
CBB
| $1.92M | ﹤0.01% |
125,099
-27,823
| -18% | -$426K |
|
2497
Hope Bancorp
HOPE
$1.78B
| $1.92M | ﹤0.01% |
127,358
-976
| -0.8% | -$13K |
|
2498
Tactile Systems Technology
TCMD
$533M
| $1.91M | ﹤0.01% |
35,128
+9,095
| +35% | +$487K |
|
2499
Evercore
EVR
$11.2B
| $1.91M | ﹤0.01% |
14,516
-26,262
| -64% | -$3.21M |
|
2500
OceanFirst Financial
OCFC
$1.84B
| $1.91M | ﹤0.01% |
79,781
+3,335
| +4% | +$71.7K |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.